Waters Co. (NYSE:WAT) Expected to Post Quarterly Sales of $632.87 Million

Equities research analysts expect Waters Co. (NYSE:WATGet Rating) to report $632.87 million in sales for the current quarter, Zacks reports. Five analysts have provided estimates for Waters’ earnings, with the lowest sales estimate coming in at $629.60 million and the highest estimate coming in at $635.00 million. Waters posted sales of $608.55 million in the same quarter last year, which suggests a positive year over year growth rate of 4%. The business is scheduled to report its next quarterly earnings report before the market opens on Monday, January 1st.

On average, analysts expect that Waters will report full year sales of $2.92 billion for the current year, with estimates ranging from $2.91 billion to $2.94 billion. For the next year, analysts anticipate that the business will report sales of $3.08 billion, with estimates ranging from $3.06 billion to $3.10 billion. Zacks’ sales averages are an average based on a survey of sell-side analysts that follow Waters.

Waters (NYSE:WATGet Rating) last released its quarterly earnings results on Tuesday, May 3rd. The medical instruments supplier reported $2.80 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.33 by $0.47. The business had revenue of $690.60 million during the quarter, compared to analyst estimates of $634.08 million. Waters had a return on equity of 239.12% and a net margin of 24.87%. Waters’s revenue for the quarter was up 13.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.29 earnings per share.

Several research analysts recently issued reports on WAT shares. SVB Leerink dropped their price objective on Waters from $375.00 to $350.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 2nd. StockNews.com began coverage on Waters in a report on Thursday, March 31st. They set a “buy” rating for the company. Finally, Wells Fargo & Company upgraded Waters from an “underweight” rating to an “equal weight” rating and reduced their target price for the stock from $320.00 to $315.00 in a research note on Monday, April 25th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $373.83.

Shares of WAT stock opened at $326.93 on Wednesday. The company has a market cap of $19.75 billion, a PE ratio of 29.24, a price-to-earnings-growth ratio of 3.02 and a beta of 0.85. The stock’s 50 day simple moving average is $313.46 and its two-hundred day simple moving average is $331.63. Waters has a 1 year low of $288.32 and a 1 year high of $428.22. The company has a debt-to-equity ratio of 4.12, a current ratio of 2.39 and a quick ratio of 1.87.

Institutional investors and hedge funds have recently modified their holdings of the business. Metis Global Partners LLC grew its position in shares of Waters by 80.1% in the first quarter. Metis Global Partners LLC now owns 967 shares of the medical instruments supplier’s stock valued at $300,000 after purchasing an additional 430 shares during the last quarter. Securian Asset Management Inc. grew its holdings in Waters by 1.9% during the 1st quarter. Securian Asset Management Inc. now owns 5,241 shares of the medical instruments supplier’s stock worth $1,627,000 after acquiring an additional 100 shares in the last quarter. FDx Advisors Inc. grew its holdings in Waters by 5.0% during the 1st quarter. FDx Advisors Inc. now owns 776 shares of the medical instruments supplier’s stock worth $241,000 after acquiring an additional 37 shares in the last quarter. National Asset Management Inc. boosted its holdings in shares of Waters by 13.1% in the 1st quarter. National Asset Management Inc. now owns 848 shares of the medical instruments supplier’s stock valued at $264,000 after buying an additional 98 shares during the period. Finally, Mutual of America Capital Management LLC boosted its holdings in shares of Waters by 1.0% in the 1st quarter. Mutual of America Capital Management LLC now owns 8,161 shares of the medical instruments supplier’s stock valued at $2,533,000 after buying an additional 84 shares during the period. Institutional investors own 90.65% of the company’s stock.

About Waters (Get Rating)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Stories

Get a free copy of the Zacks research report on Waters (WAT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.